MONECO Advisors’s AstraZeneca AZN Stock Holding History

MONECO Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$633K	Buy	3,336 +101	+3%	+$19K	0.04%	328
2026 Q1	$638K	Buy	3,235 +148	+5%	+$28.5K	0.05%	265
2025 Q4	$568K	Sell	3,087 -21	-0.7%	-$3.68K	0.05%	284
2025 Q3	$477K	Buy	3,108 +1,428	+85%	+$216K	0.04%	312
2025 Q2	$235K	Sell	1,680 -45	-3%	-$6.31K	0.02%	427
2025 Q1	$253K	Sell	1,725 -24	-1%	-$3.47K	0.03%	397
2024 Q4	$229K	Buy	1,749 +343	+24%	+$48K	0.02%	424
2024 Q3	$219K	Buy	1,406 +110	+8%	+$17.8K	0.03%	404
2024 Q2	$202K	Buy	+1,296	New	+$195K	0.03%	409

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MONECO Advisors's AZN Position: Q2 2026 in Review

MONECO Advisors increased its AstraZeneca (AZN) stake by 3.1% in Q2 2026, buying an estimated $19K and bringing the position to 3,336 shares worth $633K. The position accounts for 0.04% of the portfolio, ranked #328.

MONECO Advisors first reported a position in AZN in Q2 2024 and has held it in 9 quarters since. The position peaked at $638K in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

MONECO Advisors held 3,336 shares of AstraZeneca worth $633K as of Q2 2026.
MONECO Advisors bought 101 AstraZeneca shares in Q2 2026, an estimated $19K.
AstraZeneca made up 0.04% of MONECO Advisors's portfolio in Q2 2026, its #328 holding.
MONECO Advisors first reported a position in AstraZeneca in Q2 2024 and has held it in 9 quarters since.
MONECO Advisors's AstraZeneca position peaked at $638K in Q1 2026.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on MONECO Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.